AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Sodium-Glucose Transporter 2

Showing 1 to 2 of 2 articles

Clear Filters

Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic Review.

Reviews in cardiovascular medicine 31032602
In this systematic review, we sought to summarize the 3 recent sodium-glucose cotransporter 2 inhibitor (SGLT2i) trials (Dapagliflozin Effect on CardiovasculAR Events (DECLARE-TIMI 58), Canagliflozin Cardiovascular Assessment Study (CANVAS) Program, ...
Benzhydryl Compounds Biomarkers Blood Glucose Canagliflozin Cardiovascular Diseases Cause of Death Comorbidity Diabetes Mellitus, Type 2 Glucosides Health Status Humans Kidney Diseases Randomized Controlled Trials as Topic Research Design Risk Factors Sodium-Glucose Transporter 2 Sodium-Glucose Transporter 2 Inhibitors Treatment Outcome
View on PubMed DOI

Decoding empagliflozin's molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence.

Scientific reports 34103605
The use of sodium-glucose co-transporter 2 inhibitors to treat heart failure with preserved ejection fraction (HFpEF) is under investigation in ongoing clinical trials, but the exact mechanism of action is unclear. Here we aimed to use artificial int...
Artificial Intelligence Benzhydryl Compounds Glucosides Heart Failure Humans Models, Cardiovascular Myocardium Sodium-Glucose Transporter 2 Sodium-Glucose Transporter 2 Inhibitors Sodium-Hydrogen Exchanger 1 Stroke Volume
View on PubMed DOI
Popular Topics
Recent Journals